Merrimack PharmaceuticalsStock Price and Value Analysis

Should you buy Merrimack Pharmaceuticals stock? (NasdaqGM:MACK). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

MACK Free Cash Flow Trend

Hmm, we can't give any reliable projection for Merrimack Pharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for MACK
Free Cash Flow trendline for Merrimack Pharmaceuticals

Inside the MACK Numbers

MACK Price
(Merrimack Pharmaceuticals stock price per share)
$10.18
[?] PE Ratio versus Sector 98% lower than other Healthcare stocks
[?] PE Ratio versus Industry 99% lower than other Biotechnology stocks
[?] Cash Yield -83.63%
[?] Free Cash Flow Jitter 37%
[?] Dividend Yield 0%

Is Merrimack Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Merrimack Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MACK Stock?

Does Merrimack Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.